Welcome to the December issue of Sorbitol China News
Regarding company performance, CSPC published its financial results for the first three quarters of 2022. During the reporting period, although the price of vitamin C declined, CSPC's sales revenue from vitamin C products still increased by 22.28% YoY.
As for the market dynamics, the EI report of the master plan for Qiqihar City (Fuyu) Bio-based New Material Circular Economy Industrial Park (2022–2023) was publicised. As for the polyols produced by bio-fermentation, this industrial park will produce sorbitol in the early stage.
There are project updates: Huakang Pharma's 2 million t/a corn deep-processing project starts construction; Well Pharma plans to sign a Non-Compete Agreement with the related party; Chimin's sorbitol & mannitol rinse solution recently obtained the Drug Registration Certificate.
In terms of production, DSM Jiangshan, one of the leading vitamin C manufacturers in the world, cut the output of its vitamin C production line.
In the export market, in Oct. 2022, China exported a total of 15,449.67 tonnes of sorbitol to 48 countries and regions, amounting to USD12,739,105.
In this monthly report, the USD/CNY exchange rate is USD1.00=CNY7.1225 (Source: The People's Bank of China, 1 Dec., 2022). Unless otherwise stated, all prices involved in this report include VAT.
- CSPC announces Q1–Q3 2022 financial results
- Master plan for Qiqihar City (Fuyu) Bio-based New Material Circular Economy Industrial Park
- Huakang Pharma's 2 million t/a corn deep-processing project starts construction
- Well Pharma plans to sign Non-Compete Agreement with related party
- Chimin's sorbitol & mannitol rinse solution obtains Drug Registration Certificate
- DSM Jiangshan's vitamin C production line cut production
- Analysis on China sorbitol exports in Oct. 2022
- China's ex-works prices of sorbitol, Dec. 2022


